2020 ESA/ESICM指南:围术期低氧血症患者无创呼吸支持

2020-03-05 欧洲麻醉学会 Eur J Anaesthesiol. 2020 Apr;37(4):265-279.

2020年3月,欧洲麻醉学会(ESA)联合欧洲危重病医学会(ESICM)共同发布了围术期低氧血症患者无创呼吸支持指南,低氧血症是围手术期患者潜在的危及生命的并发症,本文主要针对围术期低氧血症患者无创呼

中文标题:

2020 ESA/ESICM指南:围术期低氧血症患者无创呼吸支持

英文标题:

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: A joint ESA/ESICM guideline.

发布机构:

欧洲麻醉学会

发布日期:

2020-03-05

简要介绍:

2020年3月,欧洲麻醉学会(ESA)联合欧洲危重病医学会(ESICM)共同发布了围术期低氧血症患者无创呼吸支持指南,低氧血症是围手术期患者潜在的危及生命的并发症,本文主要针对围术期低氧血症患者无创呼吸支持提供循证指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=63f9f1c0018e737a, title=2020 ESA/ESICM指南:围术期低氧血症患者无创呼吸支持, enTitle=Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: A joint ESA/ESICM guideline., guiderFrom=Eur J Anaesthesiol. 2020 Apr;37(4):265-279., authorId=0, author=, summary=2020年3月,欧洲麻醉学会(ESA)联合欧洲危重病医学会(ESICM)共同发布了围术期低氧血症患者无创呼吸支持指南,低氧血症是围手术期患者潜在的危及生命的并发症,本文主要针对围术期低氧血症患者无创呼, cover=https://img.medsci.cn/2020312/1583943967709_2020535.jpg, journalId=0, articlesId=null, associationId=254, associationName=欧洲麻醉学会, associationIntro=欧洲麻醉学会(ESA)是由前欧洲麻醉医师协会(ESA)、欧洲麻醉学研究院(FAA)以及欧洲国家麻醉医师协会联合会(CFNSA)联合组成,在欧洲和其他地区的麻醉医师协会中具有最突出的地位。, copyright=0, guiderPublishedTime=Thu Mar 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月,欧洲麻醉学会(ESA)联合欧洲危重病医学会(ESICM)共同发布了围术期低氧血症患者无创呼吸支持指南,低氧血症是围手术期患者潜在的危及生命的并发症,本文主要针对围术期低氧血症患者无创呼吸支持提供循证指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=8353, tagName=低氧血症), TagDto(tagId=12840, tagName=围术期)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12840, guiderKeyword=围术期, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3341, appHits=150, showAppHits=0, pcHits=1022, showPcHits=3241, likes=1, shares=9, comments=11, approvalStatus=1, publishedTime=Thu Mar 12 00:49:02 CST 2020, publishedTimeString=2020-03-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 12 00:26:20 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 05:59:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1061355, encodeId=4215106135566, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ba5637689, createdName=ms4000001601399708, createdTime=Mon Oct 18 06:32:41 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948087, encodeId=293b94808eb2, content=这个共识很有价值,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6365087859, createdName=145c86f5m52(暂无昵称), createdTime=Sun Mar 14 15:01:09 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916919, encodeId=967b9169194f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856c2580531, createdName=125a2cc7m50暂无昵称, createdTime=Fri Jan 15 16:00:02 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916918, encodeId=92689169187f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Fri Jan 15 15:59:42 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907356, encodeId=fbf990e356f5, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:35:50 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-10-18 ms4000001601399708

    不错👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1061355, encodeId=4215106135566, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ba5637689, createdName=ms4000001601399708, createdTime=Mon Oct 18 06:32:41 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948087, encodeId=293b94808eb2, content=这个共识很有价值,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6365087859, createdName=145c86f5m52(暂无昵称), createdTime=Sun Mar 14 15:01:09 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916919, encodeId=967b9169194f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856c2580531, createdName=125a2cc7m50暂无昵称, createdTime=Fri Jan 15 16:00:02 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916918, encodeId=92689169187f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Fri Jan 15 15:59:42 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907356, encodeId=fbf990e356f5, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:35:50 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-03-14 145c86f5m52(暂无昵称)

    这个共识很有价值,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1061355, encodeId=4215106135566, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ba5637689, createdName=ms4000001601399708, createdTime=Mon Oct 18 06:32:41 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948087, encodeId=293b94808eb2, content=这个共识很有价值,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6365087859, createdName=145c86f5m52(暂无昵称), createdTime=Sun Mar 14 15:01:09 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916919, encodeId=967b9169194f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856c2580531, createdName=125a2cc7m50暂无昵称, createdTime=Fri Jan 15 16:00:02 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916918, encodeId=92689169187f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Fri Jan 15 15:59:42 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907356, encodeId=fbf990e356f5, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:35:50 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-01-15 125a2cc7m50暂无昵称

    点赞

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1061355, encodeId=4215106135566, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ba5637689, createdName=ms4000001601399708, createdTime=Mon Oct 18 06:32:41 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948087, encodeId=293b94808eb2, content=这个共识很有价值,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6365087859, createdName=145c86f5m52(暂无昵称), createdTime=Sun Mar 14 15:01:09 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916919, encodeId=967b9169194f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856c2580531, createdName=125a2cc7m50暂无昵称, createdTime=Fri Jan 15 16:00:02 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916918, encodeId=92689169187f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Fri Jan 15 15:59:42 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907356, encodeId=fbf990e356f5, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:35:50 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-01-15 杨群

    点赞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1061355, encodeId=4215106135566, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ba5637689, createdName=ms4000001601399708, createdTime=Mon Oct 18 06:32:41 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948087, encodeId=293b94808eb2, content=这个共识很有价值,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6365087859, createdName=145c86f5m52(暂无昵称), createdTime=Sun Mar 14 15:01:09 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916919, encodeId=967b9169194f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856c2580531, createdName=125a2cc7m50暂无昵称, createdTime=Fri Jan 15 16:00:02 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916918, encodeId=92689169187f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Fri Jan 15 15:59:42 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907356, encodeId=fbf990e356f5, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3e1436967, createdName=1269297273, createdTime=Sat Dec 12 18:35:50 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2020-12-12 1269297273

    点赞👍

    0

拓展阅读

2014 ACC/AHA非心脏手术患者围术期心血管的评估和管理指南

美国心脏病学会(ACC,American College of Cardiology) · 2014-08-01

2015 ACFAS临床共识声明:清洁择期足部手术围术期预防性抗生素的应用

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-01-24

围术期过敏反应诊治的专家共识

中华医学会麻醉学分会 · 2016-04-27

OSA患者围术期管理的专家共识

中华医学会麻醉学分会 · 2016-04-27

2016 ERAS建议:肝脏手术围术期护理指南

促进术后恢复学会(ERAS,The Enhanced Recovery After Surgery Society) · 2016-08-22

2016 围术期高血压管理专家共识

中国心胸血管麻醉学会 · 2016-03-30